Genomadix Cube CYP2C19 System
Mar 2023
440d
Genomadix, Inc.
1
Total
1
Cleared
0
Denied
Genomadix, Inc. — FDA 510(k) Submissions
Genomadix, Inc. has submitted 1 FDA 510(k) premarket notifications since 2023, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Drug Metabolizing Enzyme Genotyping Systems . Use the specialty filter in the sidebar to narrow results.
1 devices